Background The use of social media and mobile health (mHealth) apps has been increasing
in pregnancy care. However, the effectiveness of these interventions is still unclear …

Aims To analyse the safety and efficacy of direct oral anticoagulants (DOACs) in real-world
studies including atrial fibrillation (AF) patients. Methods and results Systematic review and …

Effective stroke prevention with oral anticoagulation (OAC) is the cornerstone of the
management of patients with atrial fibrillation. The use of OAC reduces the risk of stroke and …

Purpose Although direct oral anticoagulants (DOACs) are associated with an overall
favourable safety profile, the risk of gastrointestinal bleeding with DOACs compared with …

BACKGROUND: The very elderly (≥ 80 years) are at high risk of nonvalvular atrial
fibrillation and thromboembolism. Given its recent approval, the comparative effectiveness …

Objective To evaluate the efficacy and safety of oral anticoagulants for older adult patients
with atrial fibrillation (AF). Design Pairwise and network meta-analyses. Setting and …

Background Myocardial infarction (MI), stroke, peripheral arterial disease (PAD), heart
failure (HF) and chronic kidney disease (CKD) are common cardiovascular renal diseases …

Unless contraindicated, anticoagulant therapy should be prescribed to elderly patients with
atrial fibrillation. Direct-acting oral anticoagulants (DOACs) are superior to vitamin K …

Aims Limited real-world data show that rivaroxaban following dosage criteria from either
ROCKET AF [20 mg/day or 15 mg/day if creatinine clearance (CrCl)< 50 mL/min] or J …

Background The high prevalence of atrial fibrillation (AF) in the very elderly population
(aged> 80 years) might be underestimated. The elderly are at increased risk of both fatal …